Comparative study of proton pump inhibitors for triple therapy in H. pylori eradication.
Kumar
Rajesh
R
Tandon
Vishal R
VR
Bano
G
G
Kapoor
B
B
Sharma
Sunil
S
Gupta
Yudhvir
Y
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000658:Amoxicillin / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000627:therapeutic use*; D000077402:Pantoprazole; D011446:Prospective Studies; D054328:Proton Pump Inhibitors; D064750:Rabeprazole; D013272:Stomach Diseases / Q000188:drug therapy*; D014011:Tinidazole / Q000627:therapeutic use*; D016896:Treatment Outcome
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D054328:Proton Pump Inhibitors; D014011:Tinidazole; D064750:Rabeprazole; D000658:Amoxicillin; D000077402:Pantoprazole; D009853:Omeprazole